QNT Quantinuum Inc. Insider Trading

Director Prineha Narang bought 200 shares of QNT at $60.00 for $12,000.00

Prineha Narang, a Director, purchased 200 shares at $60.00 on 2026-06-05, increasing her holdings to 6,033 shares from 5,833 shares (a +3.4% increase). The purchase price of $60.00 is above the current price of $58.40 recorded three trading days later, representing a modest paper loss on the transaction timing. This is a discretionary insider buy by a board-level officer in a recently listed company (RECENT LISTING: 2 trading days), a period when foundational holders typically evaluate their initial positions. The transaction is straightforward in size and context, though limited trading history precludes meaningful pattern analysis at this early stage.

Director Joseph Jimenez purchases 66,665 shares of QNT for $3,999,900 on 2026-06-05, increasing holdings to 72,498 shares.

Joseph Jimenez, as Director, purchased 66,665 shares at $60.00 for a total value of $3,999,900.00 during the company's recent listing (2 trading days). The transaction represents a substantial expansion of his stake, with post-transaction holdings of 72,498 shares compared to pre-transaction holdings of 5,833 shares, a net change of +1142.9%. The current price stands at $58.40 as of 2026-06-08, reflecting modest movement from the transaction price. Given the minimal trading history available and the magnitude of the share acquisition relative to his prior position, this transaction warrants examination of the underlying circumstances and motivations.

CFO Nitesh Sharan buys 6,500 shares of QNT at $60.00 in private placement allocation

Nitesh Sharan, CFO of Quantinuum Inc., purchased 6,500 shares at $60.00 on 2026-06-05 as part of a private placement allocation, not a discretionary open-market trade. The transaction increased his holdings from 334.3K shares to 340.8K shares (a 1.9% increase). While a cluster pattern is present with 2 other insiders also buying within the past 14 days, the allocation-based nature of this purchase means it does not reflect insider conviction or stock-picking judgment. QNT is in a recent listing phase (2 trading days old), making conventional valuation comparisons premature. The stock has moved to $58.40 as of 2026-06-08, slightly below the transaction price.

QNT Director Hal Barron buys 250,000 shares for $15.0M; 3 other insiders bought in past 14 days (cluster pattern)

Director Hal Barron purchased 250,000 shares of Quantinuum at $60.00 on 2026-06-05, increasing his holdings from 5,833 shares to 255,833 shares, representing a +4286.0% increase in position size. This transaction comes during Quantinuum's first 2 trading days post-listing and is part of a broader insider buying cluster: 3 other insiders also acquired shares within the same 14-day window. The concentrated buying by multiple board members immediately following the IPO suggests alignment with the company's market entry, though the recent listing date means no meaningful historical price or valuation context is yet available for comparison.

Director Eric Branderiz bought 8,334 shares of QNT at $60.00 ($500,040 total); 4 other insiders also bought within 14 days

Eric Branderiz, a Director at Quantinuum Inc., purchased 8,334 shares at $60.00 on 2026-06-05, increasing his holdings from 5,833 shares to 14,167 shares (a +142.9% increase). The stock is trading at $58.40 as of 2026-06-08, just 2 trading days after the purchase. Most notably, this transaction is part of a cluster pattern: 4 other insiders also bought within the past 14 days, indicating coordinated accumulation activity near the recent listing. With QNT being a recent listing (2 trading days old), the 52-week metrics are not yet meaningful, but the multi-insider buying pattern at and near the IPO price warrants attention as a potential signal of insider conviction during the early trading window.

Director Vimal Kapur bought 13,000 shares of QNT at $60.00 ($780.0K) on 2026-06-05; part of cluster with 5 other insiders buying in past 14 days.

Vimal Kapur, a director, purchased 13,000 shares at $60.00 for a total value of $780.0K shortly after the company's recent listing. This transaction is part of a coordinated pattern: 5 other insiders also made purchases within the past 14 days, indicating synchronized buying activity among the leadership team. The stock currently trades at $58.40 as of 2026-06-08, two trading days post-purchase. The cluster of insider purchases in the immediate post-listing window warrants scrutiny regarding early shareholder conviction during the early trading period.

Director Michal Stepniak bought 13,333 shares of QNT at $60.00 ($799,980.00); 6 other insiders bought in past 14 days.

Michal Stepniak, a Director, executed a substantial initial purchase of 13,333 shares at $60.00 on 2026-06-05, just days after Quantinuum's recent listing. This transaction is notable in isolation given the size ($799,980.00) and the timing—a director's first documented stake in the company at post-IPO entry. More significantly, this purchase is part of a broader pattern: 6 other insiders have also bought within the past 14 days, forming a cluster buy pattern. This coordinated insider accumulation immediately following the listing suggests alignment among leadership on valuation at the post-IPO price, though the recent listing status and limited trading history preclude analysis of whether such purchases correlate with subsequent returns. Investors should monitor whether this initial cluster maintains or expands its positions in coming quarters.

Chief Strategy Officer Kevin Scott Dehoff bought 15,000 shares of QNT at $60.00 ($900.0K); part of IPO allocation, not open-market conviction signal.

Kevin Scott Dehoff purchased 15,000 shares at $60.00 on 2026-06-05, totaling $900,000.00, as part of Quantinuum's recent listing allocation rather than a discretionary open-market purchase. His holdings increased 13.5% to 126,460 shares post-transaction. Seven other insiders also bought within the past 14 days, consistent with IPO-stage allocation patterns where insiders receive shares as part of the listing process. This cluster activity is typical for newly public companies and does not reflect independent conviction-driven buying decisions by individual executives.

Director Paul R. Daugherty bought 4,000 shares of QNT at $60.00 on 2026-06-05; 8 other insiders also bought within 14 days

Paul R. Daugherty purchased 4,000 shares at $60.00, increasing his stake from 5,833 shares to 9,833 shares (+68.6% vs pre-transaction holdings). The transaction occurred 2 trading days before the current price of $58.40. Within the same 14-day window, 8 other insiders also made purchases, establishing a cluster buy pattern. Given the very recent listing status (2 trading days), longer-term price comparisons and historical valuation context are not yet available. The concentration of insider buying activity across multiple participants within a narrow timeframe is a factual pattern that warrants investor attention.

Director Kenneth D Denman bought 14,000 shares of QNT at $60.00 ($840,000.00) on 2026-06-05; 9 other insiders also bought within 14 days

Kenneth D Denman, a director, purchased 14,000 shares at $60.00 for a total value of $840,000.00, increasing his holdings from 5,833 shares to 19,833 shares (+240.0% vs pre-transaction holdings). This transaction occurs in the context of a cluster pattern: 9 other insiders also bought within the past 14 days. The stock is trading at $58.40 as of 2026-06-08, within 2 trading days of this purchase. The cluster buy activity across multiple insiders within a 14-day window is a notable pattern that merits investor attention.